Shares in Puma Biotechnology jumped 40% after the FDA trod lightly around doubts about its filing for approval of breast cancer drug neratinib. But the talking points raised ahead of Wednesday’s ...
Sales meet expectations as Americas return to growth Order book 'building quarter over quarter' Puma increasing production of Palermo shoes Puma wins first big marathon podium spot in decades Shares ...
German sportswear brand Puma has recorded a jump in first-quarter profits to EUR109m (US$132m) from EUR36m a year earlier, with CEO Bjorn Gulden upbeat about the year ahead despite ongoing uncertainty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback